Roswell Park Metastatic Breast Cancer Studies Focus on New Immunotherapies

May 2, 2019 | Breast Cancer, Cancer, mBc, Metastatic Cancer, Oncology, Roswell Park Comprehensive Cancer Center

Mateusz Opyrchal, MD, PhD, Associate Director of the Early Phase Clinical Trials Program writes despite considerable advances and promising developments of late, metastatic breast cancer (mBC) continues to be a killer.

The impact and effectiveness of immunotherapy strategies for mBC treatment is an ongoing project. New strategies with powerful scientific underpinning are now in pursuit including a number of clinical trials at Roswell Park Comprehensive Cancer Center, Buffalo New York.  Follow the link below to the source at Onclive to read more from Dr. Opyrchal’s important article.

Lead Research/Investigator

Mateusz Ophychal, MD, PhD


Pin It on Pinterest